Article
Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
Annals of surgery - 1 Aug 2013
Oshima Minoru, Okano Keiichi, Muraki Shinobu, Haba Reiji, Maeba Takashi, Suzuki Yasuyuki, Yachida Shinichi
Abstract excerpt
OBJECTIVE: The goal of this retrospective study was to clarify the clinical implications of the status of the 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4). BACKGROUND: Recent whole-exome sequencing had shown that the landscape of the pancreatic ductal adenocarcinoma (PDAC) genome is notable for 4 frequently mutated genes (KRAS, TP53, CDKN2A/p16, and SMAD4/DPC4). METHODS: We determined immunohistochemically...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
